Health
2026 Nobel Prize in Medicine awarded for brain research tool called optogenetics
Publication: STAT
Author: Annalisa Merelli
Source published: 05/10/2026, 10:00:11 UTC
Briefing created: 05/10/2026, 10:37:16 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 05/10/2026, 10:36:24 UTC.
Briefings
The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their development of optogenetics, a technique using light and genetic modifications to control individual neurons in living brains. This breakthrough enables researchers to observe how nerve cells influence memories, emotions, and behavior, with potential applications in treating neurological diseases. The study was published in 2026, marking a significant advancement in neuroscience research.
Key points
- Three researchers received the 2026 Nobel Prize in Physiology or Medicine for developing optogenetics, a method combining light and genetic modifications to control individual neurons in living brains.
- The technique allows scientists to observe how nerve cells shape memories, feelings, and behavior, with ongoing research into its use as a treatment for various neurological diseases.
Context and limitations
The evidence covers the 2026 Nobel Prize announcement and the foundational work of the three laureates. Specific experimental details, patient outcomes, or long-term clinical trial results are not provided in the source material.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 05/10/2026, 10:37:16 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeigbxpj5vptswqe4623kezskj24cennva3pxtno4ytstqxzbuvs6eq